News

Travere Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for traditional approval of FILSPARI (sparsentan) ...
Your fingernails, as small as they are, can act as indicators of your overall health, offering subtle clues about potential ...
According to a PubMed Central report, uterine fibroids are the most common benign tumors found in reproductive-aged women of ...
Secondary hypertension is when your blood pressure gets elevated due to another health condition or medications. On World ...
It is not known how to prevent it. One in 1,500 children are born with this problem. The blockage occurs as the kidney is forming. Today most cases are found using ultrasound before birth. Though it ...
The U.S. FDA has approved GE HealthCare’s Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent for use in pediatric patients. The latest ...
GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication ...
The Food and Drug Administration (FDA) has approved Optison ™ (perflutren protein-type A microsphere) injectable suspension for use in pediatric patients with suboptimal echocardiograms to opacify the ...
Does your child have blood pressure issues, pain with urination, back pain near their kidneys or blood in their urine? Morgan Needham, a physician assistant (PA) with St. Luke’s Pediatric ...
Does your child have blood pressure issues, pain with urination, back pain near their kidneys or blood in their urine? Morgan Needham, a physician assistant (PA) with St. Luke’s Pediatric ...
The Jordan Times on MSN6d
A small kidney, a big lesson
When six-month-old Sanad was born with a cleft palate, his doctors suspected a possible link to other conditions — especially ...
CalciMedica Inc. ("CalciMedica" or the "Company") , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...